Showing results (421-430 of 495) with videos related to
Sort By:
Pageof 50
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2022
18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter StudyElin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.Oncotarget|April 23, 2016
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parametersBarbara Brouwers, Sigrid Hatse, Lissandra Dal Lago, et al.Journal of Cancer Research and Clinical Oncology|January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohortS Thijssen, H Wildiers, K Punie, et al.Diabetes Care|September 27, 2024
Advanced Hybrid Closed-Loop Therapy Compared With Standard Insulin Therapy Intrapartum and Early Postpartum in Women With Type 1 Diabetes: A Secondary Observational Analysis From the CRISTAL Randomized Controlled TrialKaat Beunen, Pieter Gillard, Nancy Van Wilder, et al.The Journal of Clinical Endocrinology and Metabolism|November 12, 2020
Women with Mild Fasting Hyperglycemia in Early Pregnancy Have More Neonatal Intensive Care AdmissionsKatrien Benhalima, Paul Van Crombrugge, Carolien Moyson, et al.Journal of Clinical Medicine|October 17, 2018
A Modified Two-Step Screening Strategy for Gestational Diabetes Mellitus Based on the 2013 WHO Criteria by Combining the Glucose Challenge Test and Clinical Risk FactorsKatrien Benhalima, Paul Van Crombrugge, Carolien Moyson, et al.Journal of Clinical Medicine|March 22, 2019
Prediction of Glucose Intolerance in Early Postpartum in Women with Gestational Diabetes Mellitus Based on the 2013 WHO CriteriaKatrien Benhalima, Paul Van Crombrugge, Carolien Moyson, et al.Acta Diabetologica|January 10, 2020
Estimating the risk of gestational diabetes mellitus based on the 2013 WHO criteria: a prediction model based on clinical and biochemical variables in early pregnancyKatrien Benhalima, Paul Van Crombrugge, Carolien Moyson, et al.EJNMMI Research|June 1, 2023
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patientsLennert Boeckxstaens, Elin Pauwels, Vincent Vandecaveye, et al.Journal of Neuroendocrinology|June 5, 2024
Clinical impact of using [18F]AlF-NOTA-octreotide PET/CT instead of [68Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trialHannes Leupe, Elin Pauwels, Timon Vandamme, et al.Pageof 50